Allarity Therapeutics Statistics
Total Valuation
ALLR has a market cap or net worth of $1.68 million. The enterprise value is -$15.44 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, before market open.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ALLR has 1.41 million shares outstanding.
| Current Share Class | 1.41M |
| Shares Outstanding | 1.41M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +215.59% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 2.17% |
| Float | 1.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.14 |
| P/TBV Ratio | 0.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.75, with a Debt / Equity ratio of 0.10.
| Current Ratio | 2.75 |
| Quick Ratio | 2.71 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18.69 |
Financial Efficiency
Return on equity (ROE) is -391.95% and return on invested capital (ROIC) is -156.13%.
| Return on Equity (ROE) | -391.95% |
| Return on Assets (ROA) | -55.10% |
| Return on Capital (ROIC) | -156.13% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$5.86M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -298,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.62% in the last 52 weeks. The beta is 0.29, so ALLR's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | -99.62% |
| 50-Day Moving Average | 1.76 |
| 200-Day Moving Average | 55.64 |
| Relative Strength Index (RSI) | 29.60 |
| Average Volume (20 Days) | 298,125 |
Short Selling Information
The latest short interest is 179,436, so 12.70% of the outstanding shares have been sold short.
| Short Interest | 179,436 |
| Short Previous Month | 111,774 |
| Short % of Shares Out | 12.70% |
| Short % of Float | 12.70% |
| Short Ratio (days to cover) | 0.30 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.10M |
| Pretax Income | -11.56M |
| Net Income | -35.18M |
| EBITDA | -15.09M |
| EBIT | -15.10M |
| Earnings Per Share (EPS) | -$66.84 |
Full Income StatementBalance Sheet
The company has $18.46 million in cash and $1.34 million in debt, giving a net cash position of $17.13 million or $12.12 per share.
| Cash & Cash Equivalents | 18.46M |
| Total Debt | 1.34M |
| Net Cash | 17.13M |
| Net Cash Per Share | $12.12 |
| Equity (Book Value) | 12.96M |
| Book Value Per Share | 8.23 |
| Working Capital | 12.95M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |